IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This prospective cohort study is designed to examine the association between blood and urine biomarkers (including genetic variants) and long-term kidney disease progression among 2000 Chinese IgA nephropathy patients with relatively normal kidney function (eGFR≥60 ml/min/1.73 m2).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Healthy Volunteers: f
View:
• Male or female individuals aged 14 years or older
• Patients with biopsy-proven primary IgA nephropathy
• A renal biopsy available for reviewing must include 10 or more glomeruli.
• The first renal biopsy was performed within 3 years.
• eGFR ≥ 60 ml/min/1.73 m2 (MDRD formula);
• Individuals or their legal representative who are able to understand and have voluntarily signed the informed consent form (ICF).
Locations
Other Locations
China
The First Affiliated Hospital,Sun Yat-sen University
RECRUITING
Guangzhou
Contact Information
Primary
Xue Qing Yu, M.D. & Ph.D.
yuxq@mail.sysu.edu.cn
8620-87766335
Time Frame
Start Date: 2016-11
Estimated Completion Date: 2027-01
Participants
Target number of participants: 2000
Treatments
IgA nephropathy group
Eligible biopsy-proven primary IgA nephropathy patients.
Related Therapeutic Areas
Sponsors
Leads: Sun Yat-sen University